This assumption is also supported by in situ hybridization and immunohistochemical studies, showing that MCP-1 expression and infiltrating cells of the monocyte/macrophage lineage were only detectable in premalignant precursor cells, but absent in high-grade lesions of cervical cancer patients [7,16,17]. This evidence concerns the gene CCL2 and cervical cancer.